For instance, CDCA3 has been implicated in promoting proliferation and metastasis in breast cancer by regulating the cell cycle [23], while CDCA5 has been shown to enhance chemoresistance and tumor growth in ovarian cancer [56]. Here, CDCA5 is linked to breast carcinoma.